Published in J Vasc Interv Radiol on September 01, 2002
Problematic declots: complications and irritations. Semin Intervent Radiol (2004) 0.78
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med (2011) 4.51
Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology (2006) 2.63
The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem (2009) 1.61
Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder. BJU Int (2014) 1.57
Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474. Cancer Res (2004) 1.39
Rapid modulation of long-term depression and spinogenesis via synaptic estrogen receptors in hippocampal principal neurons. J Neurochem (2007) 1.34
Clinical guidelines for overactive bladder. Int J Urol (2009) 1.27
Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat (2006) 1.25
Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure. Biochem Biophys Res Commun (2011) 1.13
Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells. J Am Soc Nephrol (2004) 1.12
Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. Urology (2008) 1.10
Endovascular treatment of ureteroarterial fistulas with stent-grafts. Radiat Med (2008) 1.08
Transient receptor potential channel A1 involved in sensory transduction of rat urinary bladder through C-fiber pathway. Urology (2007) 1.07
Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J Immunol (2009) 1.05
Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology (2010) 1.05
Clinical guideline for male lower urinary tract symptoms. Int J Urol (2009) 1.02
Corticosterone acutely prolonged N-methyl-d-aspartate receptor-mediated Ca2+ elevation in cultured rat hippocampal neurons. J Neurochem (2002) 1.02
Rapid spinogenesis of pyramidal neurons induced by activation of glucocorticoid receptors in adult male rat hippocampus. Biochem Biophys Res Commun (2005) 1.01
Rapid modulation of synaptic plasticity by estrogens as well as endocrine disrupters in hippocampal neurons. Brain Res Rev (2007) 1.01
Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms--ASSIST, randomized controlled study. Urology (2011) 1.01
Rapid, transient induction of ER stress in the liver and kidney after acute exposure to heavy metal: evidence from transgenic sensor mice. FEBS Lett (2007) 0.99
Overexpression of epithelial sodium channels in epithelium of human urinary bladder with outlet obstruction. Urology (2004) 0.98
Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin Ther (2005) 0.97
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatment. J Thorac Oncol (2012) 0.97
The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis (2003) 0.96
Comparison between basal and apical dendritic spines in estrogen-induced rapid spinogenesis of CA1 principal neurons in the adult hippocampus. Biochem Biophys Res Commun (2006) 0.94
Continuous, noninvasive monitoring of local microscopic inflammation using a genetically engineered cell-based biosensor. Lab Invest (2005) 0.93
Metastatic uveal tumor secondary to testicular choriocarcinoma. Jpn J Ophthalmol (2004) 0.93
Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol (2006) 0.92
Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. Urology (2010) 0.92
Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. J Thorac Oncol (2015) 0.92
DRESSA: biosensing of dioxin and dioxin-like chemicals using secreted alkaline phosphatase. Anal Biochem (2004) 0.92
Involvement of hypoxia-triggered endoplasmic reticulum stress in outlet obstruction-induced apoptosis in the urinary bladder. Lab Invest (2008) 0.92
Estrogen induces rapid decrease in dendritic thorns of CA3 pyramidal neurons in adult male rat hippocampus. Biochem Biophys Res Commun (2005) 0.91
Amiloride-sensitive ion channels in urinary bladder epithelium involved in mechanosensory transduction by modulating stretch-evoked adenosine triphosphate release. Urology (2007) 0.91
Synergistic effects of PDGF-BB and cAMP-elevating agents on expression of connexin43 in mesangial cells. Am J Physiol Renal Physiol (2005) 0.89
Real-time monitoring of mesangial cell-macrophage cross-talk using SEAP in vitro and ex vivo. Kidney Int (2005) 0.89
Hippocampal cytochrome P450s synthesize brain neurosteroids which are paracrine neuromodulators of synaptic signal transduction. Biochim Biophys Acta (2003) 0.89
Selection of autophagy or apoptosis in cells exposed to ER-stress depends on ATF4 expression pattern with or without CHOP expression. Biol Open (2013) 0.88
Roles of mechanosensitive ion channels in bladder sensory transduction and overactive bladder. Int J Urol (2008) 0.88
Sex-related differences in activity of lower urinary tract in response to intravesical acid irritation in decerebrate unanesthetized mice. Am J Physiol Regul Integr Comp Physiol (2008) 0.88
Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells. J Biol Chem (2011) 0.88
Effects of urethane on reflex activity of lower urinary tract in decerebrate unanesthetized rats. Am J Physiol Renal Physiol (2012) 0.87
Treatment of abdominal malignancy invading the vena cava: a report of seven cases. Surg Today (2007) 0.87
Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: a possible involvement in irritative bladder symptoms. BJU Int (2009) 0.87
Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system. Br J Pharmacol (2006) 0.87
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer. Int J Urol (2006) 0.87
Relationship of bladder dysfunction to lesion site in multiple sclerosis. J Urol (2003) 0.87
Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients. Oncol Rep (2012) 0.85
Nonsteroidal anti-inflammatory drug flufenamic acid is a potent activator of AMP-activated protein kinase. J Pharmacol Exp Ther (2011) 0.84
Functional roles of TRPV1 channels in lower urinary tract irritated by acetic acid: in vivo evaluations of the sex difference in decerebrate unanesthetized mice. Am J Physiol Renal Physiol (2010) 0.84
Prospective study evaluating the plasma concentrations of twenty-six cytokines and response to morphine treatment in cancer patients. Anticancer Res (2011) 0.84
A novel mass spectrometry-based assay for diagnosis of EML4-ALK-positive non-small cell lung cancer. J Thorac Oncol (2012) 0.84
Current and future directions in diagnostic markers in interstitial cystitis. Int J Urol (2003) 0.84
Incontinence and detrusor dysfunction associated with pelvic organ prolapse: clinical value of preoperative urodynamic evaluation. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.84
5'-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-P38 signaling pathway. Mol Pharmacol (2013) 0.83
Intraperitoneal rupture of giant hydronephrosis due to ureteral cancer accompanied by renal cell carcinoma. J Urol (2002) 0.83
Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction. BJU Int (2010) 0.83
A novel salvage technique that does not require catheter removal for exit-site infection. Perit Dial Int (2002) 0.81
Inhibition of c-Jun N-terminal kinase ameliorates apoptosis induced by hydrogen peroxide in the kidney tubule epithelial cells (NRK-52E). Nephron (2002) 0.81
Defining overactive bladder as hypersensitivity. Neurourol Urodyn (2007) 0.81
Purinergic control of AMPK activation by ATP released through connexin 43 hemichannels - pivotal roles in hemichannel-mediated cell injury. J Cell Sci (2014) 0.81
Diagnosis and treatment of voiding symptoms. Urology (2003) 0.80
Multifocal metastases of recurrent renal cell carcinoma successfully treated with a combination of low dose interleukin-2, alpha-interferon and radiotherapy. Int J Urol (2005) 0.80
ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer (2006) 0.80
Long-term gefitinib treatment of occult lung carcinoma with multiple brain metastases. Lung Cancer (2012) 0.80
Decreased expression of the epithelial Ca2+ channel TRPV5 and TRPV6 in human renal cell carcinoma associated with vitamin D receptor. J Urol (2011) 0.80
Role of cytochrome p450 in synaptocrinology: endogenous estrogen synthesis in the brain hippocampus. Drug Metab Rev (2006) 0.80
A string pattern regression algorithm and its application to pattern discovery in long introns. Genome Inform (2002) 0.79
β-Catenin signaling contributes to platelet derived growth factor elicited bladder smooth muscle cell contraction through up-regulation of Cx43 expression. J Urol (2012) 0.79
Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor. Cancer Sci (2012) 0.79